Proceedings for 4th Jagiellonian Symposium on Advances in Particle Physics and Medicine [PDF]
, 2022 Ewa Stępień, P. Moskal
openalex +1 more source
Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting
Molecular Oncology, EarlyView.CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia +9 more
wiley +1 more source
N.-L. Cordero (ed.), Parmenides: Venerable and Awesome. Proceedings of the International Symposium, Buenos Aires, October 29-November 2, 2007. Las Vegas: Parmenides Publishing, 2011. Pp. xvi, 414, US$ 65.- (pb.) ISBN 9781930972339. [PDF]
, 2013 Svetla Slaveva‐Griffin
openalex +1 more source
PLEA BARGAIN AS A GUARANTEE OF ENSURING INDIVIDUAL RIGHTS IN CRIMINAL PROCEEDINGS [PDF]
, 2021 Дилдора Базарова
openalex +1 more source
Molecular Oncology, EarlyView.Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz +15 more
wiley +1 more source
On physical and (or) psychic malefunctions in criminal proceedings
, 2017 K.S. Sefikurbanov, A.H. Oganesyan
openalex +1 more source
Advances in X-ray analysis, Vol. 19. Proceedings of 24th Annual Conference on Application of X-ray Analysis, Aug. 6-8, 1975edited by R. W. Gould, C. S. Barrett, J. B. Newkirk and C. O. Ruud [PDF]
, 1977 E. W. John Michell, T. A. Read
openalex +1 more source
LHC: Past, Present, and Future
, 2013 In this overview talk, I give highlights of the first three years of the LHC operations at high energy, spanning heavy-ion physics, standard model measurements, and searches for new particles, which culminated in the discovery of the Higgs boson by the ...
Landsberg, Greg
core
Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway
Molecular Oncology, EarlyView.Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed +10 more
wiley +1 more source